Andrew Murphy Net Worth & Insider Trades

Andrew Murphy - EVP Research, Regeneron Pharmaceuticals, Inc

As of August 17, 2022

What is Andrew Murphy's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals, Inc's EVP Research, Andrew Murphy, is estimated to be about $62.06M . Andrew Murphy owns about 62,760 units of Regeneron Pharmaceuticals, Inc common stock. In the last 3 years at Regeneron Pharmaceuticals, Inc, Andrew Murphy has sold an estimated value of $64.72M worth.

What is Andrew Murphy's Past Insider Trading?

Andrew Murphy's largest purchase order was 10,000 units , worth over $1.79M on August 17, 2022. Andrew Murphy's largest sale order was 18,620 units , worth over $11.65M on July 15, 2020. In total, Andrew Murphy has made about 13 transactions over 3 years of their time at Regeneron Pharmaceuticals, Inc. Andrew Murphy usually trades in December, with the busiest year in 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Andrew Murphy's Salary in 2020?

As EVP Research of Regeneron Pharmaceuticals, Inc, Andrew Murphy has a total base salary of $726,923 . Andrew Murphy received compensation valued at about $10,998,914 in 2020 after becoming EVP Research. The vast majority of their compensation came in the form of stock awards of $5,025,288 , other earnings, plans or compensations of $887,250 , other earnings, plans or compensations of $887,250 , and other compensation of $24,195 .

What is Andrew Murphy's' Mailing Address?

  • Mailing address is Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 NY

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?

Regeneron Pharmaceuticals, Inc's most recent insider trade came on October 7, 2022 by Christopher R Fenimore who sold 1,844 units worth $1.38M . In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.4B and bought an estimated value of $3.47B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1